Brief: Biosyent BioSyent Pharma wins Canada approval for Aguettant System
May 5 (Reuters) - Biosyent Inc RX.V
* Biosyent pharma receives health canada approval for new
urgent care product using the aguettant system(r)
Source text for Eikon: ID:nMKWTNfRwa
Further company coverage: RX.V
(Bengaluru Newsroom +1-646-223-8780)
Recent news on Biosyent
See all newsCanada's BioSyent Q2 revenue jumps 95% following Oral Health acquisition
Canada's BioSyent Q1 revenue rises helped by Oral Science acquisition
Brief: Biosyent Announces Closing Of The Acquisition Of Oral Science Inc.
Brief: Biosyent To Acquire Oral Science Inc.
Brief: Biosyent Announces Renewal Of Normal Course Issuer Bid